
|Articles|February 5, 2007
Democrats reopen debate on Medicare Part D
The Democrats opened a new salvo in the battle over the Medicare drug benefit with the introduction of the Medicare Prescription Drug Price Negotiation Act of 2007. The bill, which passed the House mostly along party lines, mandates that the Secretary of the Department of Health & Human Services (DHHS) negotiate directly with drug companies over drug prices charged to prescription drug plans (PDPs). Still, the bill's future and how it will impact pharmacy remains unclear.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Overcoming the Structural Squeeze Through Policy and Coordination
2
Navigating Compounding Peptides and GLP-1s Through Regulations
3
Pharmacist Involvement Speeds Prior Authorization for GLP-1s
4
The 2026 GLP-1 Compounding Crackdown: A Pharmacist’s Guide
5


























